Maude Bouscambert‐Duchamp

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

François-Xavier Lescure, Lila Bouadma, Duc Nguyen et al. · The Lancet Infectious Diseases · 2020 · 1.2K citations · Full text

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020

Kostas Danis, Olivier Épaulard, Thomas Bénet et al. · Clinical Infectious Diseases · 2020 · 263 citations · Full text

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

Xavier Duval, Sylvie van der Werf, Thierry Blanchon et al. · PLoS Medicine · 2010 · 126 citations · Full text

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader, Nathan Peiffer‐Smadja, Julien Poissy et al. · Clinical Microbiology and Infection · 2021 · 102 citations · Full text

Clinical Infectious Disease, Open-label Randomized, Antiviral Drug Development +6